These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 8620509)
1. Aberrant hypermethylation at the bcl-2 locus at 18q21 in human lung cancers. Nagatake M; Osada H; Kondo M; Uchida K; Nishio M; Shimokata K; Takahashi T; Takahashi T Cancer Res; 1996 Apr; 56(8):1886-91. PubMed ID: 8620509 [TBL] [Abstract][Full Text] [Related]
2. Detailed deletion mapping suggests the involvement of a tumor suppressor gene at 17p13.3, distal to p53, in the pathogenesis of lung cancers. Konishi H; Takahashi T; Kozaki K; Yatabe Y; Mitsudomi T; Fujii Y; Sugiura T; Matsuda H; Takahashi T; Takahashi T Oncogene; 1998 Oct; 17(16):2095-100. PubMed ID: 9798680 [TBL] [Abstract][Full Text] [Related]
3. Reduced transcription of the RB2/p130 gene in human lung cancer. Xue Jun H; Gemma A; Hosoya Y; Matsuda K; Nara M; Hosomi Y; Okano T; Kurimoto F; Seike M; Takenaka K; Yoshimura A; Toyota M; Kudoh S Mol Carcinog; 2003 Nov; 38(3):124-9. PubMed ID: 14587097 [TBL] [Abstract][Full Text] [Related]
4. Hypermethylation of the GATA genes in lung cancer. Guo M; Akiyama Y; House MG; Hooker CM; Heath E; Gabrielson E; Yang SC; Han Y; Baylin SB; Herman JG; Brock MV Clin Cancer Res; 2004 Dec; 10(23):7917-24. PubMed ID: 15585625 [TBL] [Abstract][Full Text] [Related]
5. Frequent inactivation of RASSF1A, BLU, and SEMA3B on 3p21.3 by promoter hypermethylation and allele loss in non-small cell lung cancer. Ito M; Ito G; Kondo M; Uchiyama M; Fukui T; Mori S; Yoshioka H; Ueda Y; Shimokata K; Sekido Y Cancer Lett; 2005 Jul; 225(1):131-9. PubMed ID: 15922865 [TBL] [Abstract][Full Text] [Related]
6. Mechanisms of p16INK4A inactivation in non small-cell lung cancers. Gazzeri S; Gouyer V; Vour'ch C; Brambilla C; Brambilla E Oncogene; 1998 Jan; 16(4):497-504. PubMed ID: 9484839 [TBL] [Abstract][Full Text] [Related]
7. Frequent amplification of the bcl-1 locus in poorly differentiated squamous cell carcinoma of the lung. The Lung Cancer Study Group. Berenson JR; Koga H; Yang J; Pearl J; Holmes EC; Figlin R Oncogene; 1990 Sep; 5(9):1343-8. PubMed ID: 2170896 [TBL] [Abstract][Full Text] [Related]
11. SLIT2, a human homologue of the Drosophila Slit2 gene, has tumor suppressor activity and is frequently inactivated in lung and breast cancers. Dallol A; Da Silva NF; Viacava P; Minna JD; Bieche I; Maher ER; Latif F Cancer Res; 2002 Oct; 62(20):5874-80. PubMed ID: 12384551 [TBL] [Abstract][Full Text] [Related]
12. Frequent and histological type-specific inactivation of 14-3-3sigma in human lung cancers. Osada H; Tatematsu Y; Yatabe Y; Nakagawa T; Konishi H; Harano T; Tezel E; Takada M; Takahashi T Oncogene; 2002 Apr; 21(15):2418-24. PubMed ID: 11948426 [TBL] [Abstract][Full Text] [Related]
13. Deletion mapping on the short arm of chromosome 3 in squamous cell carcinoma and adenocarcinoma of the lung. Yokoyama S; Yamakawa K; Tsuchiya E; Murata M; Sakiyama S; Nakamura Y Cancer Res; 1992 Feb; 52(4):873-7. PubMed ID: 1346586 [TBL] [Abstract][Full Text] [Related]
14. DNA hypermethylation at the D17S5 locus in non-small cell lung cancers: its association with smoking history. Eguchi K; Kanai Y; Kobayashi K; Hirohashi S Cancer Res; 1997 Nov; 57(21):4913-5. PubMed ID: 9354457 [TBL] [Abstract][Full Text] [Related]
15. [Clinicopathological study on primary lung cancer--immunohistochemical expression of p53 suppressor gene and bcl-2 oncogene in relation to prognosis]. Irie K; Ishida H; Furukawa T; Koyanagi K; Miyamoto Y Rinsho Byori; 1996 Jan; 44(1):32-41. PubMed ID: 8691638 [TBL] [Abstract][Full Text] [Related]
16. Somatic in vivo alterations of the DPC4 gene at 18q21 in human lung cancers. Nagatake M; Takagi Y; Osada H; Uchida K; Mitsudomi T; Saji S; Shimokata K; Takahashi T; Takahashi T Cancer Res; 1996 Jun; 56(12):2718-20. PubMed ID: 8665501 [TBL] [Abstract][Full Text] [Related]
17. High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints. Wistuba II; Behrens C; Virmani AK; Mele G; Milchgrub S; Girard L; Fondon JW; Garner HR; McKay B; Latif F; Lerman MI; Lam S; Gazdar AF; Minna JD Cancer Res; 2000 Apr; 60(7):1949-60. PubMed ID: 10766185 [TBL] [Abstract][Full Text] [Related]
18. Increase in the frequency of p16INK4 gene inactivation by hypermethylation in lung cancer during the process of metastasis and its relation to the status of p53. Seike M; Gemma A; Hosoya Y; Hemmi S; Taniguchi Y; Fukuda Y; Yamanaka N; Kudoh S Clin Cancer Res; 2000 Nov; 6(11):4307-13. PubMed ID: 11106248 [TBL] [Abstract][Full Text] [Related]
19. Molecular genetics of small cell lung carcinoma. Wistuba II; Gazdar AF; Minna JD Semin Oncol; 2001 Apr; 28(2 Suppl 4):3-13. PubMed ID: 11479891 [TBL] [Abstract][Full Text] [Related]
20. A novel tumor suppressor locus on chromosome 18q involved in the development of human lung cancer. Takei K; Kohno T; Hamada K; Takita J; Noguchi M; Matsuno Y; Hirohashi S; Uezato H; Yokota J Cancer Res; 1998 Aug; 58(16):3700-5. PubMed ID: 9721881 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]